SEARCH RESULT

Total Matching Records found : 993

Dr David Berger, director of the British Medical Journal group and a general physician practising in Australia, speaks to Rema Nagarajan

-The Times of India Dr David Berger, director of the British Medical Journal group and a general physician practising in Australia, is better known in India for an article he wrote in the BMJ in May last year titled 'Corruption ruins the doctor-patient relationship in India' based on his experiences of working in India. The article sparked a public debate on the widespread corruption in India's healthcare sector. Here now on...

More »

Lie of the land: Only 39 of 133 GM crop field trials monitored in 6 years -Dipu Rai

-DNA The Centre has always claimed that the country has a robust regulatory mechanism Busting the claims of the Indian government and scientists that the country has a robust regulatory mechanism to test genetically modified (GM) crops, toxic loopholes are emerging. From 2008 to 2014, only 39 of the 133 GM crop field trials were properly monitored, leaving the rest for unknown risks and possible health hazards to common people. Documents accessed...

More »

40% Indians exposed to second hand smoke at home: WHO -Sushmi Dey

-The Times of India NEW DELHI: Even as the government is still deliberating on larger pictorial warnings on packs of tobacco products, 40% of Indian adults are exposed to second hand tobacco smoke at home. These are people who do not smoke themselves but are vulnerable to various diseases because someone smokes at home, showed a latest assessment by the World Health Organization, highlighting risks of second hand smoking and the need...

More »

Indians face risk from unproven drugs: Lancet -Rupali Mukherjee

-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...

More »

New Health Policy and Chronic Disease: Analysis of Data and Evidence -Subrata Mukherjee, Anoshua Chaudhuri, and Anamitra Barik

-Economic and Political Weekly The Ministry of Health and Family Welfare has made public the National Health Policy 2015 Draft for discussion. The draft is more exhaustive and better organised in its coverage compared to the National Health Policy of 2002. It touches upon contemporary issues of concern, including the rapid emergence of chronic non-communicable diseases. From the latest available evidence, issues crucial to tackling chronic illness in India are discussed. Subrata...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close